Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norovirus Bivalent VLP Vaccine in Healthy Adults
NCT01609257Phase 2Completed
- Sponsor
- Takeda
- Start
- Jul 2012
- Primary completion
- Mar 2014
- Modality
- Viral Vector Vaccines, Drug Delivery Systems, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of norovirus bivalent vaccine in norovirus infection, acute gastroenteritis, sponsored by Takeda. Started Jul 2012; status: completed.
02
Drugs
norovirus bivalent vaccine
03
Conditions
norovirus infectionacute gastroenteritis
Beyond the preview
Go deeper on NCT01609257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01609257.